Northern Trust Corp Ultragenyx Pharmaceutical Inc. Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Northern Trust Corp holds 568,389 shares of RARE stock, worth $21.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
568,389
Previous 528,965 7.45%
Holding current value
$21.2 Million
Previous $22.3 Million 7.51%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$36.21 - $45.78 $1.43 Million - $1.8 Million
39,424 Added 7.45%
568,389 $20.6 Million
Q4 2024

Feb 14, 2025
BUY
$42.07 - $57.72 $2.34 Million - $3.21 Million
55,641 Added 11.76%
528,965 $22.3 Million
Q3 2024

Nov 13, 2024
BUY
$40.21 - $59.36 $3.68 Million - $5.43 Million
91,443 Added 23.95%
473,324 $26.3 Million
Q2 2024

Aug 14, 2024
BUY
$37.42 - $51.61 $533,534 - $735,855
14,258 Added 3.88%
381,881 $15.7 Million
Q1 2024

May 14, 2024
SELL
$43.02 - $53.69 $302,774 - $377,870
-7,038 Reduced 1.88%
367,623 $17.2 Million
Q4 2023

Feb 13, 2024
BUY
$31.73 - $49.19 $1.65 Million - $2.56 Million
52,090 Added 16.15%
374,661 $17.9 Million
Q3 2023

Nov 13, 2023
BUY
$34.92 - $46.66 $356,463 - $476,305
10,208 Added 3.27%
322,571 $11.5 Million
Q2 2023

Aug 11, 2023
BUY
$37.35 - $52.15 $285,839 - $399,103
7,653 Added 2.51%
312,363 $14.4 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $255,120 - $335,952
6,897 Added 2.32%
304,710 $12.2 Million
Q4 2022

Feb 13, 2023
SELL
$33.72 - $46.33 $1.32 Million - $1.82 Million
-39,183 Reduced 11.63%
297,813 $13.8 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $60,059 - $99,408
1,503 Added 0.45%
336,996 $14 Million
Q2 2022

Aug 12, 2022
SELL
$45.8 - $85.4 $100,897 - $188,136
-2,203 Reduced 0.65%
335,493 $20 Million
Q1 2022

May 13, 2022
SELL
$62.2 - $84.4 $115,256 - $156,393
-1,853 Reduced 0.55%
337,696 $24.5 Million
Q4 2021

Feb 08, 2022
SELL
$73.71 - $87.86 $240,589 - $286,775
-3,264 Reduced 0.95%
339,549 $28.6 Million
Q3 2021

Nov 15, 2021
SELL
$77.92 - $102.4 $98,802 - $129,843
-1,268 Reduced 0.37%
342,813 $30.9 Million
Q2 2021

Aug 13, 2021
SELL
$92.19 - $115.71 $35.7 Million - $44.8 Million
-387,487 Reduced 52.97%
344,081 $32.8 Million
Q1 2021

May 12, 2021
SELL
$106.9 - $167.73 $4.73 Million - $7.42 Million
-44,223 Reduced 5.7%
731,568 $83.3 Million
Q4 2020

Feb 11, 2021
BUY
$84.4 - $177.39 $2.83 Million - $5.95 Million
33,536 Added 4.52%
775,791 $107 Million
Q3 2020

Nov 16, 2020
SELL
$72.98 - $90.0 $2.64 Million - $3.26 Million
-36,194 Reduced 4.65%
742,255 $61 Million
Q2 2020

Aug 14, 2020
BUY
$46.91 - $78.22 $2.69 Million - $4.49 Million
57,346 Added 7.95%
778,449 $60.9 Million
Q1 2020

May 14, 2020
BUY
$33.8 - $62.9 $359,969 - $669,885
10,650 Added 1.5%
721,103 $32 Million
Q4 2019

Feb 14, 2020
SELL
$36.08 - $45.83 $495,161 - $628,970
-13,724 Reduced 1.9%
710,453 $30.3 Million
Q3 2019

Nov 13, 2019
BUY
$42.5 - $63.11 $1.41 Million - $2.09 Million
33,067 Added 4.78%
724,177 $31 Million
Q2 2019

Aug 13, 2019
BUY
$54.93 - $74.36 $1.8 Million - $2.44 Million
32,812 Added 4.98%
691,110 $43.9 Million
Q1 2019

May 13, 2019
BUY
$39.87 - $69.36 $3.1 Million - $5.39 Million
77,718 Added 13.39%
658,298 $45.7 Million
Q4 2018

Feb 12, 2019
BUY
$38.89 - $77.3 $437,823 - $870,243
11,258 Added 1.98%
580,580 $25.2 Million
Q3 2018

Nov 14, 2018
BUY
$71.81 - $90.15 $1.09 Million - $1.37 Million
15,230 Added 2.75%
569,322 $43.5 Million
Q2 2018

Sep 18, 2018
SELL
$48.54 - $85.31 $154,405 - $271,371
-3,181 Reduced 0.57%
554,092 $42.6 Million
Q2 2018

Aug 14, 2018
BUY
$48.54 - $85.31 $1.85 Million - $3.25 Million
38,123 Added 7.34%
557,273 $42.8 Million
Q1 2018

May 09, 2018
BUY
$44.33 - $58.52 $2.59 Million - $3.42 Million
58,507 Added 12.7%
519,150 $26.5 Million
Q4 2017

Feb 14, 2018
SELL
$43.54 - $57.32 $495,311 - $652,072
-11,376 Reduced 2.41%
460,643 $21.4 Million
Q3 2017

Nov 13, 2017
BUY
$49.79 - $66.32 $23.5 Million - $31.3 Million
472,019
472,019 $25.1 Million

Others Institutions Holding RARE

# of Institutions
336
Shares Held
88.9M
Call Options Held
1.08M
Put Options Held
1.04M
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.62B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email